Covid19
7 competing products in clinical development for Covid19.
Pipeline by Phase
Phase 11
Phase 1/21
Phase 23
Phase 31
Approved1
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Favipiravir + Nitazoxanide | Strides Pharma | Phase 2 | Completed | 35 |
| DS-5670a + Placebo | Daiichi Sankyo | Phase 1/2 | Completed | 32 |
| AVIGAN + Placebo Comparator | Dr. Reddy's Laboratories | Phase 3 | Terminated | 29 |
| Pegylated Interferon-α2b | Zydus Lifesciences | Phase 2 | Terminated | 27 |
| Icosapent ethyl | Amarin Corporation | Approved | Terminated | 25 |
| GX-03 + Petrolatum ointment | Turn Therapeutics | Phase 2 | Completed | 25 |
| Cytotoxic T Lymphocytes | Tevogen Bio | Phase 1 | Completed | 19 |